The Shifting Sands of Healthcare: Pharmacists as Frontline Care Providers?

A proposed legislative shift is igniting a heated discussion within the Belgian healthcare community. The core of the debate revolves around expanding the pharmacist’s role beyond dispensing medication to include preventive care and basic diagnostics. This potential transformation, while lauded by some as a solution to overburdened general practitioners (gps), is met with skepticism and resistance from others who fear it undermines the GP’s central role in patient care.

Addressing Healthcare Accessibility: A Necessary Evolution?

the argument for expanding pharmacists’ duties ofen centers on improving healthcare accessibility. With GPs facing increasingly packed schedules and rising patient demand, especially in early detection and prevention, pharmacists are presented as a readily available alternative. Their strategic locations, extended hours, and walk-in accessibility make them ideal candidates for performing simple diagnostics and measurements, possibly streamlining care delivery. For example, in rural areas where access to a GP might be limited, a local pharmacist could provide crucial initial assessments.

Currently, many countries face challenges in healthcare access.According to a 2024 report by the World Health Organization, approximately 3.5 billion people lack full coverage of essential health services. Utilizing pharmacists more effectively could be a step towards bridging this gap.

The Proposed Legislative Changes: A Closer Look at the WUG Law

The proposed changes target the Health Professions Act (WUG), which currently restricts pharmacists to medication dispensing. The amendment seeks to authorize pharmacists to conduct point-of-care tests, including rapid tests for infectious diseases like COVID-19, influenza, and strep throat. Moreover, they could perform measurements such as blood glucose and HbA1c tests via finger pricks, as well as initial testing for suspected urinary tract infections. This expansion requires amending the legislation to explicitly authorize pharmacists to detect diseases and defections and autonomously perform simple interventions like blood pressure measurements.

Concerns and Criticisms: Undermining the General Practitioner’s Role?

However, this proposed expansion is not without its detractors. Dr. Stijn Geysenbergh of the BVAS (Belgian Association of medical Syndicates) views the WUG law amendment as a step too far, arguing that it further undresses the role of the general practitioner under the guise of public benefit. He emphasizes that diagnosing and treating illnesses should remain the doctor’s responsibility, not the pharmacist’s. This sentiment is echoed by Dr. Jos Vanhoof of the Flemish Doctors Syndicate, who believes that care delegation should not be seen as subsidiary care, where responsibility is handed over entirely. He asserts that while pharmacists have value within the patient’s care team, they should not assume full responsibility for care coordination.

Tracing and treating diseases is the job of the doctor, not from the pharmacist. The only one that nobody wants to take over from the doctor is to fill in the countless management.

Dr. Stijn Geysenbergh, BVAS

Delegation vs. Subsidiary Care: A Crucial Distinction

Dr. Vanhoof highlights the critical difference between delegation and subsidiary care. In delegation, the doctor entrusts specific tasks while retaining overall responsibility for the patient’s care. In contrast, subsidiary care involves transferring both the task and the responsibility to another healthcare provider. Critics argue that the proposed changes risk blurring this line, potentially leading to fragmented care and a diminished role for the GP as the central coordinator.

You cannot see care delegation as subsidiary care.In the case of subsidiary care you hand over the care and responsibility, at zorgdelegatie you trust care, but you maintain responsibility.

Dr. Jos Vanhoof, Flemish Doctors Syndicate

The Path Forward: Collaboration or Conflict?

the debate surrounding the expanding role of pharmacists underscores the need for a clear and collaborative approach to healthcare reform. While pharmacists can undoubtedly contribute to improving accessibility and efficiency, it is crucial to define their responsibilities in a way that complements, rather than undermines, the role of the general practitioner. open dialogue and careful consideration of the potential implications are essential to ensure that any changes ultimately benefit patients and strengthen the overall healthcare system.